Aspirin should not be used to prevent a first heart attack or stroke in patients with no history of cardiovascular disease, according to the U.S. Food and Drug Administration (FDA).
Current European and American guidelines recommend the perioperative initiation of a course of ?-blockers in those at risk of cardiac events undergoing high- or intermediate-risk surgery or vascular surgery.
The purpose of this study was to evaluate the role of congestive heart failure in the association between atrial fibrillation and sudden cardiac death.
We aimed to assess the impact of eplerenone on cardiovascular (CV) outcomes in STEMI without known heart failure, when initiated within 24 h of symptom onset.
Concomitant use of aspirin or an NSAID during anticoagulant therapy was associated with an increased risk for clinically relevant and major bleeding in patients with venous thromboembolism, according to study results.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.